Caitlin Bowne (Bille)
About Caitlin Bowne (Bille)
Caitlin Bowne is the Director at Alkermes in Waltham, Massachusetts, with extensive experience in supply chain management and expertise in cold chain logistics, label design, and rare disease and oncology sectors.
Current Role at Alkermes
Caitlin Bowne is currently serving as Director at Alkermes in Waltham, Massachusetts, United States. In this leadership role, she is responsible for overseeing key aspects of the company's operations, leveraging her extensive experience in supply chain management and cold chain logistics.
Previous Experience at Alkermes
Before becoming Director, Caitlin Bowne was the Associate Director of Clinical Supply Chain at Alkermes. From 2018 to 2022, she played a critical role in managing clinical supply chain operations, ensuring the seamless transportation and storage of clinical supplies, particularly temperature-sensitive products.
Career at Aegerion Pharmaceuticals
Caitlin Bowne worked at Aegerion Pharmaceuticals in Cambridge, Massachusetts, holding roles as Associate Director from 2017 to 2018 and Senior Supply Chain Manager from 2015 to 2017. During her tenure, she was instrumental in optimizing supply chain processes and contributing to the success of the company's clinical and commercial operations.
Early Roles in Pharmaceutical Supply Chain
Caitlin Bowne's career in the pharmaceutical industry includes positions such as Clinical Supply Chain Manager at ARIAD Pharmaceuticals, Inc. from 2013 to 2015, and Senior Specialist in Label Development at Biogen Idec in 2013. She also worked at AVEO Pharmaceuticals as Senior Project Coordinator from 2011 to 2013, and at Millennium Pharmaceuticals as Quality Assurance Specialist in 2010 and 2011.
Education and Expertise
Caitlin Bowne holds a Bachelor of Science degree in Meteorology from Plymouth State University, where she studied from 2003 to 2008. Her professional expertise encompasses cold chain logistics, clinical and commercial label and package design, and supply chain management in the rare disease and oncology sectors. She is also experienced in biologics and small molecule supply chain management and competitor/co-med sourcing.